Proven efficacy of tacrolimus for facial and intertriginous psoriasis

Archives of Dermatology

Volumn 141, Issue 9, 2005, Pages 1154-

  Lebwohl, Mark ^a   Freeman, Amy ^a   Chapman, M Shane ^a   Feldman, Steven ^a   Hartle, Jennifer ^a   Henning, Alice ^a  

^a Box 1048 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CORTICOSTEROID; TACROLIMUS;

CLINICAL TRIAL; DRUG EFFICACY; FACE; HUMAN; LIMB; NOTE; PRIORITY JOURNAL; PSORIASIS; SCALP; SKIN DISEASE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TRUNK;

ADMINISTRATION, TOPICAL; DERMATOLOGIC AGENTS; FACIAL DERMATOSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PSORIASIS; TACROLIMUS; TREATMENT OUTCOME;

EID: 25444504028     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.9.1154     Document Type: Note

References (6)

1. Bigby M. Pimecrolimus and tacrolimus for the treatment of intertriginous and facial psoriasis: are they effective? Arch Dermatol. 2005;141:1152-1153.
2. Lebwohl M, Freeman AK, Chapman MS, et al. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004;51:723-730.
3. Freeman AK, Linowski GJ, Brady C, et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol. 2003;48:564-568.
4. Tan MH, Meador SL, Singer G, Lebwohl MG. An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas. Int J Dermatol. 2002;41:804-809.
5. Lebwohl MG, Tan MH, Meador SL, Singer G. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol. 2001;44:77-82.
6. Lebwohl M, Peets E, Chen V. Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy. Int J Dermatol. 1993;32:830-831.